1970, J Clin Invest., 49, 381, 10.1172/JCI106247
10.1148/radiology.212.2.r99au27499
10.3171/jns.2007.106.4.526
1991, Cancer Res., 51, 3316
1996, Radiat Res., 145, 491, 10.2307/3579071
2001, Optical Tomography and Spectroscopy of Tissue IV., 4250, 429, 10.1117/12.434524
2003, Adv Exp Med Biol., 530, 19, 10.1007/978-1-4615-0075-9_3
Oxylite 2000 instrument. Oxford Optronix, Oxford, U.K. Available at: http://www.oxfordoptronix.com. Accessed May 12, 2008.
10.1667/0033-7587(2001)156[0510:TODWRT]2.0.CO;2
10.1016/j.ijrobp.2005.03.009
2004, Methods Enzymol., 386, 378, 10.1016/S0076-6879(04)86018-X
10.1016/j.neuroimage.2006.10.044
1994, Invest Radiol., 29, S161, 10.1097/00004424-199406001-00053
10.1259/0007-1285-26-312-638
1996, Semin Radiat Oncol., 6, 10, 10.1016/S1053-4296(96)80032-4
1979, Int J Radiat Oncol Biol Phys., 5, 851, 10.1016/0360-3016(79)90070-1
10.1016/S0360-3016(96)00325-2
1991, Cancer Res., 51, 6098
10.1016/S0360-3016(97)00101-6
1994, Adv Exp Med Biol., 345, 485, 10.1007/978-1-4615-2468-7_65
10.1016/0167-8140(91)90182-G
10.1016/0167-8140(93)90025-4
1998, Radiother Oncol., 48, 146
1996, Cancer Res., 56, 941
10.1016/j.ceb.2006.10.005
10.1016/S0968-0004(98)01344-9
10.1007/s10555-007-9054-2
1979, N Engl J Med., 301, 1429, 10.1056/NEJM197912273012606
1981, Br J Cancer., 43, 546, 10.1038/bjc.1981.79
Rasey JS, Martin GV, Krohn KA. Quantifying hypoxia with radiolabeled fluoromisonidazole: pre-clinical and clinical studies. In: Machulla H-J, ed. The Imaging of Hypoxia. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1999:85–117.
10.1080/09553000601002324
10.1007/s00330-006-0431-y
10.1053/j.semnuclmed.2007.07.001
10.1002/1097-0142(19841201)54:11<2441::AID-CNCR2820541122>3.0.CO;2-S
1985, Cancer Res., 45, 1692
1987, J Nucl Med., 28, 68
1992, J Nucl Med., 33, 2202
McClelland RA. Molecular interactions and biological effects of the products of reduction of nitroimidazoles. In: Adams GE, Breccia A, Fiedlen EN, Wardman P, eds. NATO Advanced Research Workshop on Selective Activation of Drugs by Redox Processes. New York, NY: Plenum Press; 1990:125–136.
10.1016/0006-2952(91)90245-Z
10.1007/s00259-003-1322-y
2003, Adv Exp Med Biol., 510, 285, 10.1007/978-1-4615-0205-0_47
10.1158/1078-0432.CCR-06-1563
1980, Cancer Clin Trials., 3, 237
1982, Int J Radiat Oncol Biol Phys., 8, 335, 10.1016/0360-3016(82)90634-4
1978, Br J Cancer Suppl., 37, 264
10.1016/0006-2952(90)90086-Z
1978, Br J Cancer., 3, 268
1978, Br J Cancer Suppl., 3, 286
Paget GE. Toxicity tests: a guide for clinicians. In: Heinrich AD, Cattell M, eds. Clinical Testing of New Drugs. New York, NY: Revere Publishing Co.; 1965.
1990, Circ Res., 67, 240, 10.1161/01.RES.67.1.240
Caldwell JH, Martin GV, Rasey JS, Krohn KA. Imaging myocardial hypoxia with positron emission tomography. In: Sidemen S, Beyar R, eds. Imaging, Measurement, and Analysis of the Heart. Washington, DC: Hemisphere Publishing Co.; 1991:323–333.
10.1016/0883-2889(86)90079-1
1989, J Nucl Med., 30, 343
10.1016/0969-8043(93)90110-V
NCI-CIP Web site. Available at: http://imaging.cancer.gov/programsandresources/Cancer-Tracer-Synthesis-Resources. Accessed October 25, 2007.
2007, J Labelled Comp Radiopharm., 50, S423
1997, J Nucl Med., 38, 1631
10.1016/j.rcl.2004.08.004
10.1016/S0360-3016(00)00467-3
10.1016/j.ijrobp.2006.11.061
2001, J Clin Oncol., 19, 535, 10.1200/JCO.2001.19.2.535
2004, J Nucl Med., 45, 1851
2003, Eur J Nucl Med Mol Imaging., 30, 695, 10.1007/s00259-002-1096-7
10.1158/1078-0432.CCR-0688-3
10.1007/s00066-004-1229-y
2006, J Nucl Med., 47, 410
2006, J Nucl Med., 47, 1921
10.1007/s11307-007-0095-2
2005, J Nucl Med., 46, 253
10.1016/S0167-8140(03)00081-1
10.1158/1078-0432.CCR-05-1773
10.1158/1535-7163.MCT-06-0125
1999, J Nucl Med., 40, 1072
10.1007/s00259-002-1016-x
10.1007/s00259-003-1404-x
1999, Biol Pharm Bull., 22, 590, 10.1248/bpb.22.590
10.1016/S0969-8051(02)00442-0
10.1007/s00259-007-0424-3
2005, J Nucl Med., 46, 106
10.1007/s00259-003-1322-y
2004, Br J Cancer., 90, 2232, 10.1038/sj.bjc.6601862
2000, J Nucl Med., 41, 327
10.1007/s00259-007-0376-7
2003, Eur J Nucl Med., 30, 259, 10.1007/s00259-002-1037-5
2001, Appl Radiat Isot., 43, 73
1997, J Nucl Med., 38, 1155
2007, Dalton Trans., 43, 4893
1990, J Nucl Med., 31, 1989
10.1016/j.nucmedbio.2005.05.003
10.1016/j.ijrobp.2004.12.057
2007, Int J Oncol., 30, 873
1999, J Nucl Med., 40, 177
2001, J Nucl Med., 42, 655
2002, J Nucl Med., 43, 1557
10.1007/s00259-003-1130-4
10.1007/s11307-007-0095-2
10.1016/S0360-3016(02)04477-2
10.1007/s00247-004-1305-6
1995, Radiology., 194, 321, 10.1148/radiology.194.2.7824705
1998, Magn Reson Med., 40, 494, 10.1002/mrm.1910400322
10.1016/S0730-725X(99)00089-2
1998, Int J Radiat Oncol Biol Phys., 41, 151, 10.1016/S0360-3016(98)00038-8
10.3109/02841869709001308
10.1016/S0167-8140(98)00043-7
10.1016/S0360-3016(02)02825-0
10.1088/0031-9155/51/1/004
1998, Int J Radiat Oncol Biol Phys., 40, 161
10.1097/00000421-200110000-00010
2003, Adv Exp Med Biol., 530, 19, 10.1007/978-1-4615-0075-9_3
10.1016/S0360-3016(02)02822-5
2007, Int J Radiat Oncol Biol Phys., 68, 1065, 10.1016/j.ijrobp.2007.01.018
2005, Breast Cancer Res Treat., 94, S257
1993, Magn Reson Med., 29, 296, 10.1002/mrm.1910290304
Thomas SR. The biomedical applications of fluorine-19 NMR. In: Partain CL, Price RR, Patton JA, Kulkarni MV, James AEJ, eds. Magnetic Resonance Imaging. Vol. 2. London, U.K.: WB Saunders Co.; 1988;1536–1552.
10.1016/0730-725X(95)02046-V
Higuchi T, Naruse S, Horikawa Y, Hirakawa K, Tanaka C. In vivo measurement of the partial pressure of oxygen in brain tissue using 19F NMR. In: Opella SJ, ed. 7th SMRM. Burlington, MA: Elsevier Inc.;1988:435.
1993, Magn Reson Med., 29, 446, 10.1002/mrm.1910290405
10.1016/S1076-6332(05)80485-4
1992, Magn Reson Med., 27, 310, 10.1002/mrm.1910270210
1976, Arch Pathol Lab Med., 100, 213
1994, Int J Radiat Oncol Biol Phys., 29, 95, 10.1016/0360-3016(94)90231-3
10.1016/S0360-3016(00)01460-7
10.1177/153303460200100607
1994, Magn Reson Med., 32, 88, 10.1002/mrm.1910320112
10.1016/S0360-3016(98)00555-0
10.1016/0730-725X(96)00049-5
10.1002/(SICI)1099-1492(199605)9:3<125::AID-NBM405>3.0.CO;2-F
Bourke VA. Dynamic Interrogation of the Tumor Microenvironment in Response to Respiratory Challenge, Radiation Therapy, and Pharmacologic Intervention [dissertation]. Dallas, TX: UT Southwestern; 2005.
2003, Neoplasia., 5, 308, 10.1016/S1476-5586(03)80024-6
10.1667/0033-7587(2003)159[0621:COTODW]2.0.CO;2
2007, Int J Radiat Oncol Biol Phys., 67, 1179, 10.1016/j.ijrobp.2006.11.037
1984, J Environ Sci Health B., 19, 83, 10.1080/03601238409372416
Hall LW, Jackson SRK, Massey GM. Hexafluorobenzene in veterinary anaesthesia. In: Arias A, Llaurado R, Nalda MA, et al., eds. Recent Progress in Anaesthesiology and Resuscitation. Oxford, U.K.: Excerpta Medica; 1975:201–204.
1981, Gov Rep Announce Index (US)., 81, 2555
10.1016/S0360-3016(96)00559-7
2003, Clin Cancer Res., 9, 5101
1991, Cancer Commun., 3, 133, 10.3727/095535491820873353
1998, Br J Cancer., 77, 65, 10.1038/bjc.1998.10
10.1016/j.radonc.2004.07.018
10.1158/1078-0432.CCR-06-1563
2001, Int J Radiat Oncol Biol Phys., 51, 349
10.1002/(SICI)1099-1492(1998110)11:7<360::AID-NBM518>3.0.CO;2-P
10.1016/S0360-3016(01)02769-9
Glockner JF, Swartz HM. In vivo oximetry using two novel probes: fusinite and lithium phthalocyanine. In: Erdmann W, Bruley DF, eds. Oxygen Transport to Tissue XIV. New York, NY: Plenum Press; 1992:229–234.
1995, Magn Reson Med., 33, 237, 10.1002/mrm.1910330214
1998, Cancer Res., 58, 1562
10.1529/biophysj.106.099135
2003, Clin Cancer Res., 9, 59
Chemicon T. Available at: http://www.chemicon.com. Accessed October 25, 2007.
10.1016/S0360-3016(02)04503-0
10.1016/0360-3016(95)02006-3
10.1158/0008-5472.CAN-03-2424
10.1016/j.ijrobp.2005.05.068
Nighswander-Rempel SP, Kupriyanov VV, Shaw RA. Regional cardiac tissue oxygenation as a function of blood flow and pO2: a near-infrared spectroscopic imaging study. J Biomed Optics. 2006;11:054004-1-10.
1995, J Nucl Med., 36, 1633
1990, J Am Coll Cardiol., 16, 477, 10.1016/0735-1097(90)90606-P
10.1097/01.cmr.0000222605.03675.1d
10.1152/ajpregu.00707.2006
10.1016/S1389-0344(01)00107-1
2006, Cancer Res., 60, 916
2005, Mol Imaging., 4, 182
10.1158/0008-5472.CAN-04-0842
2006, J Biomed Opt., 11(2), 024015
2007, Int J Oncol., 30, 45
1986, Int J Radiat Oncol Biol Phys., 12, 1255, 10.1016/0360-3016(86)90271-3
1987, Stroke., 18, 168, 10.1161/01.STR.18.1.168
1984, Int J Radiat Oncol Biol Phys., 10, 1365, 10.1016/0360-3016(84)90350-X
10.1016/S0969-8051(00)00151-7
10.1002/1531-8249(200008)48:2<228::AID-ANA13>3.0.CO;2-B
10.1161/01.STR.0000094422.74023.FF
1989, J Nucl Med., 30, 194
10.1007/s00259-006-0135-1
1986, Int J Radiat Oncol Biol Phys., 12, 1239, 10.1016/0360-3016(86)90267-1
1993, Cancer Res., 53, 4633
10.1158/1078-0432.CCR-07-0478
